Letter to the Editor
Abstract
--
References
1. Böer A. To count or not to count–that is the question. Editorial. Dermatopathology: Practical & Conceptual 2010;16(3):4.
2. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009;20; 27(36):6199-206. Epub 2009 Nov 16.
3. Brett MC, Scott D, Howard WR. Sentinel lymph node biopsy and completion lymph node dissection for malignant melanoma are not standard of care. Clin Dermatol 2009; 27:350-4.
4. GonzÁlez U. Cloud over sentinel node biopsy: unlikely survival benefit in melanoma. Arch Dermatol 2007;143(6):775-6.
5. Kanzler MH. The current status of evaluation and treatment of high-risk cutaneous melanoma: therapeutic breakthroughs remain elusive. Arch Dermatol 2007;143(6):785-87.
6. Zitelli JA. Sentinel lymph node biopsy: an alternate view. Dermatol Surg 2008;34(4):544-9. CrossRef
7. Medalie N, Ackerman AB. Sentinel node biopsy has not benefit for patients whose primary cutaneous melanoma has metastasized to lymph node and therefore should be abandoned now. Br J Dermatol 2004:151(2):298-307.
8. Thomas JM. Freedom of expression or protectionism in the debate on sentinel node biopsy in melanoma. J Am Acad Dermatol 2009;61(6):1079. CrossRef
2. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009;20; 27(36):6199-206. Epub 2009 Nov 16.
3. Brett MC, Scott D, Howard WR. Sentinel lymph node biopsy and completion lymph node dissection for malignant melanoma are not standard of care. Clin Dermatol 2009; 27:350-4.
4. GonzÁlez U. Cloud over sentinel node biopsy: unlikely survival benefit in melanoma. Arch Dermatol 2007;143(6):775-6.
5. Kanzler MH. The current status of evaluation and treatment of high-risk cutaneous melanoma: therapeutic breakthroughs remain elusive. Arch Dermatol 2007;143(6):785-87.
6. Zitelli JA. Sentinel lymph node biopsy: an alternate view. Dermatol Surg 2008;34(4):544-9. CrossRef
7. Medalie N, Ackerman AB. Sentinel node biopsy has not benefit for patients whose primary cutaneous melanoma has metastasized to lymph node and therefore should be abandoned now. Br J Dermatol 2004:151(2):298-307.
8. Thomas JM. Freedom of expression or protectionism in the debate on sentinel node biopsy in melanoma. J Am Acad Dermatol 2009;61(6):1079. CrossRef
Downloads
Published
2011-10-31
Issue
Section
Letter
License
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
1.
Achenbach R. Letter to the Editor. Dermatol Pract Concept. Published online October 31, 2011:84-85. doi:10.5826/dpc.0101a17
Share
